thc global group limited (asx:thc) smart thinking on cannabis · own australian bio-pharma factory...
TRANSCRIPT
1 THC GLOBAL GROUP LIMITED (ASX:THC)
Smart thinking on cannabis
THC Global Group Limited (ASX:THC)
Investor PresentationJune 2020
22 THC GLOBAL GROUP LIMITED (ASX:THC)
Australia’s newest pharmaceutical company - delivered
Launched Affordable Medicines Range
Acquired Clinics to Increase Accessibility
Established Export Channels
Achieved Dominant Market Position
Positioned to Lead Pharma OTC
Own Australian Bio-Pharma Factory
Complete GMP Certification (EU and TGA)
Launched Global Scale Medicines Supply
Secured Upstream Cannabis Supply
33 THC GLOBAL GROUP LIMITED (ASX:THC)
Delivering in Four Core AreasGlobal Supply of
Medicines
Direct Patient Healthcare Services
Global Supply of Medicines
Direct Patient Healthcare Services
World Class Pharma Production
Four interconnected revenue centres addressing major global barriers to industry growth
Turnkey Cultivation Solutions
44 THC GLOBAL GROUP LIMITED (ASX:THC)
Pharma Production Made World ClassScalable Production
Production capacity scalable up to 1 million patients per annum with limited additional capex.
TGA & EU GMP Licenced
Pharma GMP cannabis medicines production with full EU compliance enabling export opportunities.
Reliable Supply Secured
Access to own cultivation facilities in addition to local Aust growers, and crude extract imports.
Onsite R&D Lab
Onsite labs enables product testing and validation in addition to production required for clinical trials.
Finished Goods Diversity
Developing capability for production of capsules, tablets, creams and other finished product forms.
White Label & Own Lines
Ability to service high volume bulk processing or white-labelled orders without limiting own production.
55 THC GLOBAL GROUP LIMITED (ASX:THC)
Pharma Production at Global Scale
Third Party Brands
Canndeo Branded Medicines
Pharmaceutical API
Third Party Australian Growers
THC Global Cultivation Sites
International Raw Crude
66 THC GLOBAL GROUP LIMITED (ASX:THC)
Affordable and Accessible Medicines
Canndeo
77 THC GLOBAL GROUP LIMITED (ASX:THC)
Opening Australia’s Prescribing MarketPrescribing MarketPrescribing Market
Tetra Health
THC GLOBAL GROUP LIMITED (ASX:THC)
CanndeoCare
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
Apr-
19
May
-19
Jun-
19
Jul-1
9
Aug-
19
Sep-
19
Oct
-19
Nov
-19
Dec
-19
Jan-
20
Feb-
20
Mar
-20
Apr-
20
SAS-B Approvals
Solving theAffordability &
Accessibility Gap
88 THC GLOBAL GROUP LIMITED (ASX:THC)
Capturing theNew Pharma OTC MarketUnprecedented opportunity to dominate a new $200m+ market
$200m+ Addressable Patient Market
Order of Magnitude Volume Increase
White Label Opportunity
Canndeo Branded Medicines
THC GLOBAL GROUP LIMITED (ASX:THC)
99 THC GLOBAL GROUP LIMITED (ASX:THC)
Exporting to Global Markets
Delivering a global supply of affordable quality medicines 2020
2021+
1010 THC GLOBAL GROUP LIMITED (ASX:THC)
Smart Businesses for the Canadian MarketCanadian MarketCanadian Market
Turnkey Cultivation Solutions
THC GLOBAL GROUP LIMITED (ASX:THC)
Solutions
Medicinal Cannabis
High growth businesses developed for the Canadian market with strong profitability potential
1111 THC GLOBAL GROUP LIMITED (ASX:THC)
Laura Harvey Angela Maguire Diandra Phipps Sonny Didugu
Steven Xu Ken Charteris Jarrod White Andrew BeehagSteven Xu Ken Charteris Jarrod WhiteJarrod White Andrew BeehagBeehag
Sonny Didugu Sonny Didugu
Global Management Team
Diandra PhippsDiandra PhippsLaura HarveyLaura Harvey Angela MaguireAngela Maguire
1212 THC GLOBAL GROUP LIMITED (ASX:THC)
Capital and Financial OverviewKey Information
ASX Code ASX:THC
Listing Date May 2017
GICS Classification Pharmaceuticals, Biotechnology & Life Science
Share Price(3 June)
$0.44
Market Cap(3 June)
$64.25 million
Shares on Issue(3 June)
146,028,486
Shareholders(3 June)
8,888 Shareholders
Recent Financials
Cash(31 March)
$2.26 million + $4m debt facility
Property Plant and Equipment (2019)
$18.4 million
Existing Debt $4 million secured debt facility repayable 31 October 2021
2019 Group Revenue $4.79 million
Revenue Growth 55% YoY (2018-19)44% YoY on Q1 Cash Receipts
1313 THC GLOBAL GROUP LIMITED (ASX:THC)
Disclaimer
1414 THC GLOBAL GROUP LIMITED (ASX:THC)
CONTACT THC GLOBAL GROUPASX:THC
W E Bthc.global
C O R P O R A T E O F F I C ESuite 4102
Level 41 Austral ia Square
264-278 George Street
Sydney NSW 2000
Austral ia
E M A I [email protected]